Skip to content
Menu
Breaking Efficacy Ceilings
Home
About
Science
Pipeline
News
Careers
Triveni Bio
News
The latest company updates, news, and insights
Triveni Bio Raises $65 Million Series C Financing to Expand Scope of First-in-Class Bispecific TRIV-573 Clinical Studies and Drive Next-Stage Company Growth
Press Release
6.17.2026
Top
